Last update 21 Jul 2025

WO2023036815

Patent Mining

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms-
Target
MPIG6B
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesCardiovascular DiseasesHemic and Lymphatic Diseases+ [2]
Active Indication
Embolism and ThrombosisHematologic DiseasesImmune System Diseases+ [2]
Inactive Indication-
Originator Organization
Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche MédicaleÉtablissement Français du SangUniversity of StrasbourgUniversity of Strasbourg
Active Organization
Établissement Français du SangInstitut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche MédicaleUniversity of StrasbourgUniversity of Strasbourg
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with WO2023036815
Login to view more data
100 Translational Medicine associated with WO2023036815
Login to view more data
100 Patents (Medical) associated with WO2023036815
Login to view more data
100 Deals associated with WO2023036815
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Embolism and ThrombosisDiscovery-
Établissement Français du Sang
16 Mar 2023
Embolism and ThrombosisDiscovery-
University of StrasbourgUniversity of Strasbourg
16 Mar 2023
Embolism and ThrombosisDiscovery-
Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche Médicale
16 Mar 2023
Hematologic DiseasesDiscovery-
Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche Médicale
16 Mar 2023
Hematologic DiseasesDiscovery-
University of StrasbourgUniversity of Strasbourg
16 Mar 2023
Hematologic DiseasesDiscovery-
Établissement Français du Sang
16 Mar 2023
Immune System DiseasesDiscovery-
Établissement Français du Sang
16 Mar 2023
Immune System DiseasesDiscovery-
Institut National de la Santé et de la Recherche MédicaleInstitut National de la Santé et de la Recherche Médicale
16 Mar 2023
Immune System DiseasesDiscovery-
University of StrasbourgUniversity of Strasbourg
16 Mar 2023
Skin and Musculoskeletal DiseasesDiscovery-
University of StrasbourgUniversity of Strasbourg
16 Mar 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free